Articles related to CLINICAL DECISION SUPPORT (CDS)

OpenAI introduced clinician-tailored ChatGPT capabilities for documentation, evidence synthesis, and patient education, with several major academic centers as early enterprise adopters.

The American Epilepsy Society released the first dedicated treatment guideline for infantile epilepsy. Two strong surgical recommendations sit alongside conditional pharmacological and dietary guidance.

Algorithm-guided treatment was associated with improved remission rates in 5 of 7 randomized trials of major depressive disorder, though heterogeneity in protocols and outcome measures limited direct comparability.

“Like many people, I often oscillate between excitement about the potential for AI to benefit humanity, while at other times I am fearful of ways it may be misused or cause harm.” – Ann Wieben, PhD, MS, BSN, RN, NI-BC

“What we call ‘algorithmovigilance’ is an emerging role for pharmacists… This is akin to pharmacovigilance, the discipline of mining real-world data to detect drug safety concerns.” – Ravi Patel, PharmD

Digital platforms are enabling oncologists to access global expertise through virtual tumor boards, particularly benefiting practitioners in resource-limited settings who previously lacked access to multidisciplinary consultation.